International Federation of Clinical Chemistry
International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring
Abstract
Issues surrounding the measurement and interpretation of immunosuppressive drug concentrations have been summarized in a number of consensus documents. The Scientific Division of the International Federation of Clinical Chemistry has formed a working group in collaboration with the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. This paper sets out the goals of the working group in light of the developments that have occurred in the field of immunosuppressive drug monitoring since the publication of the last consensus documents.
Source and rights
Published by Therapeutic drug monitoring, 2002. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- International Federation of Clinical Chemistry
- Published
- 2002
- Applies to
- 🌐 International
- Scope
- Regional
- Journal
- Therapeutic drug monitoring
- PubMed
- 11805724
- Added to Prognia
More in emergency medicine
- ESR Essentials: Trauma Team and the Role of Interventional RadiologyCardiovascular and Interventional Radiological Society of Europe (CIRSE) · 2026
- Guidelines for Essential Trauma Care: Second Edition (2026)International Association for Trauma Surgery and Intensive Care (IATSIC) and the World Health Organization (WHO) · 2026
